CFTR and cystic fibrosis: To date, the standard of care for the majority of children with CF is symptomatic therapy based on mucolytic treatments with the availability of CFTR modulating drugs for only a small group of infants with gating mutations and preschool children homozygous for Phe508del [24,27,147,148].